MT-061 lead series (MaxThera)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMT-061 lead series (MaxThera)
Drug Alias Namefatty acid biosynthesis inhibitor (MaxThera)MT-061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acid synthase inhibitors
TargetsFatty acid synthase
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaxThera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaxThera Inc
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A